This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Median Technologies. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Benjamin Renoust
Introduction
Benjamin Renoust is a notable inventor based in Antibes, France. He has made significant strides in the field of medical imaging, particularly in the classification of liver diseases. His work focuses on utilizing advanced technology to improve diagnostic methods, which can have a profound impact on patient care.
Latest Patents
Renoust holds a patent for an "Automated pattern recognition and scoring method of fibrosis from non-invasive radiology imaging." This innovative method involves classifying the severity of liver diseases using non-invasive radiographic images. The process includes providing radiographic images of a patient's abdomen, pre-processing these images by segmenting the liver and spleen, and normalizing them. By extracting parameters from both the liver and spleen binary masks, the method employs a trained Machine Learning model to classify the severity of liver disease, distinguishing between early and advanced stages.
Career Highlights
Benjamin Renoust is currently associated with Median Technologies, a company that specializes in medical imaging solutions. His work at Median Technologies has allowed him to contribute to advancements in the field, particularly in the area of non-invasive diagnostics. His innovative approach has garnered attention and recognition within the medical community.
Collaborations
Renoust collaborates with esteemed colleagues such as Jean-Christophe Brisset and Pierre Baudot. Their combined expertise enhances the research and development efforts at Median Technologies, fostering an environment of innovation and progress.
Conclusion
Benjamin Renoust's contributions to medical imaging and diagnostics exemplify the power of innovation in healthcare. His patented method for assessing liver disease severity represents a significant advancement in non-invasive imaging techniques. Through his work, Renoust continues to pave the way for improved patient outcomes and enhanced diagnostic capabilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile